29.09.2021 - Andera Partners - Publications

The role of private equity in the recovery in France and Europe: an opportunity for investors

Combined Shape

16.09.2021 - andera Life Sciences - Press releases

Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management

Combined Shape

10.09.2021 - andera Acto - Press releases

Andera Acto supports DP Software Group in its development strategy

Combined Shape

09.09.2021 - andera Life Sciences - Press releases

Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…

Combined Shape

08.09.2021 - Andera Partners - Press releases

Andera Partners strengthens its investment teams and reaffirms its growth ambition

Combined Shape

02.08.2021 - andera Life Sciences - Press releases

T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

Combined Shape

27.07.2021 - andera Life Sciences - Press releases

Artios Pharma has completed a $153 million series C

Combined Shape

26.07.2021 - andera MidCap - Press releases

Andera Partners and the KLUBB Group’s founder join forces

Combined Shape

23.07.2021 - Andera Partners - Press releases

Andera Partners publishes its first Climate & Sustainability Report

Combined Shape

22.07.2021 - andera Expansion/Croissance - Press releases

Andera Expansion acquires MC2 Technologies

Combined Shape

08.07.2021 - andera MidCap - Press releases

Andera Partners sells its majority stake in Infra Group

Combined Shape

06.07.2021 - andera MidCap - Press releases

Andera MidCap sells its stake in Minafin

Combined Shape

05.07.2021 - andera Life Sciences - Press releases

TRiCares announces the successful first in human implantations of “Topaz”

Combined Shape

23.06.2021 - andera Life Sciences - Press releases

Poxel announces the approval of Twymeeg

Combined Shape

18.06.2021 - andera MidCap - Press releases

Andera sells its stake in Netco Group

Combined Shape

04.05.2021 - andera Life Sciences - Press releases

Life Sciences portfolio company Gamamabs signs an agreement with Exelixis

Combined Shape

27.04.2021 - andera Life Sciences - Andera Partners - Press releases

Andera Partners strengthens its presence in the DACH region

Combined Shape

13.04.2021 - andera Infra

Internship offer – Infrastructure investment

07.04.2021 - andera Life Sciences

Artios Pharma announces collaboration with Novartis

06.04.2021 - Andera Partners - Press releases

Andera creates its own foundation

Combined Shape

09.03.2021 - Andera Partners - Press releases

Andera Partners announces the arrival of Noëlla de Bermingham as Chief Sustainability Officer

Combined Shape

02.03.2021 - andera Life Sciences - Press releases

ReViral and LianBio Announce Exclusive Collaboration

Combined Shape

26.02.2021 - andera MidCap - Press releases

Pusterla 1880 issues Sustainability-Linked Bonds to finance its growth

Combined Shape

16.02.2021 - andera Infra - Andera Partners - Press releases

Our 5th area of activity: Andera Infra

Combined Shape

10.02.2021 - andera Life Sciences - Press releases

MedLumics closes upsized EUR 18M financing round and appoints new Chairman

Combined Shape

05.02.2021 - Andera Partners - Press releases

Andera strengthens governance and targets €4-5 billion in AUM by 2025

Combined Shape

04.02.2021 - andera MidCap - Press releases

Andera MidCap sells Skill & You to IK Investment Partners

Combined Shape

13.01.2021 - andera Life Sciences

MMI appoints healthcare industry veteran Mark Toland as CEO

12.01.2021 - andera MidCap - Press releases

Andera MidCap invests in Pusterla 1880

Combined Shape

07.01.2021 - andera Life Sciences - Press releases

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

Combined Shape

05.01.2021 - andera Life Sciences - Press releases

Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics

Combined Shape

04.01.2021 - andera Life Sciences - Press releases

Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…

Combined Shape

21.12.2020 - Uncategorized - Press releases

Significant agreements with Chinese market leaders in our Life Sciences portfolio

Combined Shape

01.12.2020 - Andera Partners - Press releases

Andera Partners renames all its activities

Combined Shape

21.10.2020 - Andera Partners - Press releases

The Power of And

Combined Shape

12.10.2020 - andera Life Sciences - Press releases

Medlumics lands a 14M€ new financing round

Combined Shape

28.08.2020 - andera Life Sciences - Press releases

Reviral raises $44 million in Series C financing

Combined Shape

06.08.2020 - andera Life Sciences - Press releases

T-knife completes €66m Series A financing

Combined Shape

23.07.2020 - andera Life Sciences - Press reviews

COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19

Combined Shape

29.06.2020 - andera Acto - Press releases

ActoMezz IV: a single closing at more than €500 million

Combined Shape

11.06.2020 - andera Life Sciences - Press releases

BioDiscovery sells Corvidia to Novo Nordisk

Combined Shape

06.05.2020 - andera Life Sciences - Press releases

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

Combined Shape

06.05.2020 - andera Life Sciences - Press releases

 Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…

Combined Shape

06.05.2020 - Andera Partners - Press releases

Andera Partners welcomes Constance Jay and strengthens its Investor Relations

Combined Shape

02.04.2020 - andera Life Sciences - Press releases

Dynacure Announces €50M ($55M) Series C Financing

Combined Shape

01.04.2020 - andera Life Sciences - Press releases

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

Combined Shape

05.03.2020 - Andera Partners - Publications

Newsletter – 03/2020

Combined Shape

28.02.2020 - andera Life Sciences - Press releases

Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…

Combined Shape

27.02.2020 - Andera Partners - Press releases

2019: a new record year for Andera

Combined Shape

21.11.2019 - andera Life Sciences - Press releases

Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…

Combined Shape

15.11.2019 - andera MidCap - Press releases

Winch invests in Auxiga

Combined Shape

14.10.2019 - andera Expansion/Croissance - Press releases

Hans Van de Velde – Senior Advisor Belgium

Combined Shape

11.10.2019 - andera Life Sciences - Press releases

BioDiscovery invests in AgomAb Therapeutics

Combined Shape

16.07.2019 - andera Life Sciences - Press releases

BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.

Combined Shape

02.07.2019 - andera Expansion/Croissance - Press releases

The ORCA Group acquires Italian companies Angeloni and Impregnatex

Combined Shape

01.07.2019 - Andera Partners - Publications

ic20: Initiative Climate 2020

Combined Shape

15.05.2019 - andera MidCap - Press releases

Winch invests in Spherea

Combined Shape

05.04.2019 - andera MidCap - Press releases

Winch invests in the Belgian company Infra Group

Combined Shape

03.04.2019 - andera Acto - Press releases

ActoMezz invests in Tournus

Combined Shape

28.03.2019 - Andera Partners - Press releases

Appointments and Recruitments

Combined Shape

14.02.2019 - andera Life Sciences - Press releases

A syndicate of international investors finance Arvelle Therapeutics

Combined Shape

11.02.2019 - andera Life Sciences - Press releases

Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan

Combined Shape

28.01.2019 - andera MidCap - Press releases

NetCo welcomes IK among its shareholders, alongside Andera and the founding family

Combined Shape

18.01.2019 - Andera Partners - Press releases

2018: an emblematic year for Andera Partners

Combined Shape

03.12.2018 - andera MidCap - Press releases

Winch Capital 4: fundraising completed at €445 million

Combined Shape

05.11.2018 - andera Life Sciences - Press releases

Crescendo Biologics announces early licensing by Takeda

Combined Shape

05.11.2018 - andera Life Sciences - Press releases

Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease

Combined Shape

02.08.2018 - andera Life Sciences - Press releases

Artios Pharma Announces $86 million (£65 million) Series B Financing

Combined Shape

18.07.2018 - andera MidCap - Press releases

WINCH Capital 4: a first closing of €360m for Andera Partners mid-cap fund

Combined Shape

06.07.2018 - andera Life Sciences - Press releases

BioDiscovery invests in Dynacure to advance lead program into clinical development

Combined Shape

04.07.2018 - Andera Partners - Press releases

Renewed governance for Andera Partners

Combined Shape

04.06.2018 - andera Life Sciences - Press releases

ENYO Pharma raises €40 million in Series B fundraising

Combined Shape

04.06.2018 - andera Life Sciences - Press releases

TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…

Combined Shape

22.05.2018 - andera Life Sciences - Press releases

GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…

Combined Shape

02.05.2018 - andera Life Sciences - Press releases

Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing

Combined Shape

26.04.2018 - andera MidCap - Press releases

Andera Partners sponsors the carve-out of Conduent’s Off-Street Parking business in association with…

Combined Shape

25.04.2018 - andera Life Sciences - Press releases

Corvidia Therapeutics Secures $60 Million in Series B Funding

Combined Shape

04.04.2018 - Andera Partners - Press releases

EdRIP becomes ANDERA PARTNERS

Combined Shape
Sorry, no results.